L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability
- 3 May 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (9) , 1251-1254
- https://doi.org/10.1016/s0960-894x(99)00182-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesBioorganic & Medicinal Chemistry Letters, 1999
- Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesBioorganic & Medicinal Chemistry Letters, 1999
- 3-pyridylethanolamines: Potent and selective human β3 adrenergic receptor agonistsBioorganic & Medicinal Chemistry Letters, 1998
- 3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic propertiesBioorganic & Medicinal Chemistry Letters, 1998
- A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.Journal of Clinical Investigation, 1998
- β3 Adrenergic Receptor Agonists for the Treatment of ObesityPublished by Elsevier ,1998
- β3-adrenergic agonists: potential therapeutics for obesityExpert Opinion on Investigational Drugs, 1997
- BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITYAnnual Review of Medicine, 1997
- The potential role of β3 adrenoceptor agonists In the treatment of obesity and diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- The Synthesis of 1-Substituted 5(4H)Tetrazolinones1a,bJournal of the American Chemical Society, 1959